Monsanto Company (MON): The Company Splices In Its Competitors’ Best Traits

Monsanto Company (NYSE:MON) has been a busy bee lately. In March, Monsanto and E I Du Pont De Nemours And Co (NYSE:DD) settled multiple patent lawsuits against each other, instead agreeing to cross-license some of each other’s technology. Last week, Monsanto inked another cross-license deal with The Dow Chemical Company (NYSE:DOW) , and finally another with Bayer AG this week.

Monsanto Company (NYSE:MON)

Hard to tell where one ends and the other begins
Under the DuPont deal, E I Du Pont De Nemours And Co (NYSE:DD) will now pay Monsanto Company (NYSE:MON) $1.75 billion over 10 years to use Monsanto’s Roundup-ready soybean genes, which are used in about 90% of the soybeans grown in the United States. DuPont will also get to combine these genes with its own genes to create soybeans with multiple traits, which was the basis of Monsanto’s initial patent infringement suit. In return, aside from the $1.75 billion, E I Du Pont De Nemours And Co (NYSE:DD) will drop an antitrust lawsuit it had filed against Monsanto.

As for the The Dow Chemical Company (NYSE:DOW) deal, Monsanto Company (NYSE:MON) will get to license Dow’s herbicide-resistant corn, and in return, Dow gets to use Monsanto’s newest corn rootworm resistance technology, which is still in the pipeline.

It’s a good thing The Dow Chemical Company (NYSE:DOW) is getting the new version of the technology, because in 2011, researchers began noticing that the rootworms in some fields in Iowa had become resistant to Monsanto’s corn, which has a gene that essentially makes the corn a pesticide for that specific pest. The EPA now believes the resistant rootworms have spread to five other states in the Midwest. The EPA also notes that the Monsanto-resistant rootworms are more likely to develop a resistance to SmartStax, a combination herbicide-pesticide-resistant seed. So overall, this is a major headache for Monsanto, and the company has a lot riding on the new third version of its rootworm technology.

Finally, Monsanto Company (NYSE:MON) agreed to license its Roundup-ready soybean technology to Bayer for use in the U.S. and Canada, as well as insect-repellent soybeans for use in Brazil. Monsanto will gain access to Bayer’s weed and insect-control technology, to evaluate for incorporation into future Monsanto products.

Green fields ahead
All these deals mean more companies using Monsanto’s traits, but with 90% of the soybean market already, the bigger benefit is Monsanto Company (NYSE:MON)’s access to other companies’ technology, which will hopefully help it stay ahead of herbicide and pesticide resistant “superweeds” and “superbugs.”

Monsanto also recently raised its full-year earnings guidance for the second quarter in a row, now up to $4.40-$4.50 per share. At around $100 per share, that doesn’t make Monsanto Company (NYSE:MON)’s stock particularly cheap, but earnings are growing fast — net income grew by 22% in the recently ended quarter. This is one company to get on your Watchlist today, and stay updated with future developments as it continues to dominate the seed market.

The article Monsanto Splices In Its Competitors’ Best Traits originally appeared on Fool.com is written by Jacob Roche.

Fool contributor Jacob Roche and The Motley Fool have no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!